Michelle Andrews

Michelle Andrews is a contributing writer and former columnist for KFF Health News. She has been writing about health care for more than 15 years. Her work has appeared frequently in The New York Times, where she wrote the Money and Medicine column and contributed regular news and features. Her work has also been published in Money, Fortune Small Business, National Geographic and Women’s Health magazines, among others. Michelle previously worked as a senior writer at U.S. News & World Report and at SmartMoney magazines. She has a bachelor’s degree from the University of Wisconsin and a master’s in journalism from Columbia University.

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?

Biologic drugs, made from living organisms, and the cheaper biosimilar drugs that mimic them are more complex than chemical drugs and their generic counterparts. The Food and Drug Administration says biosimilars are as safe and effective as the biologics, and doctors agree — but they are cautious about changing the treatment regimen of patients doing well.